Literature DB >> 7826625

Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?

K Seipel1, O Georgiev, H P Gerber, W Schaffner.   

Abstract

Regions rich in serine, threonine, and proline residues can be found in transcriptional activation domains, as well as in the N-terminal parts of mammalian TATA-binding proteins, where they are interrupted by polyglutamine stretches. Likewise, the C-terminal domain of the largest subunit of RNA polymerase II contains multiple repeats of the consensus heptapeptide sequence YSPTSPS. To test directly for possible activation functions, we fused the GAL4 DNA-binding domain to the N-terminal domain of human TBP or subdomains of it, and to the C-terminal domain (CTD) of mouse RNA polymerase II or synthetic polymers of a CTD consensus repeat. We found that these chimeric proteins were able to activate transcription when bound to a GAL4 site in front of the TATA box, a function characteristic of transcription factors. However, while subdomains of TBP functioned only from a position close to the TATA box ("promoter" position), multiple repeats of the CTD consensus sequence were also able to mediate transcriptional activation from a remote ("enhancer") position. Our findings suggest that a region of TBP that is unique to mammals functionally cooperates with "proximal" activation domains of promoter-bound transcription factors. They also imply that the C-terminal domain of RNA polymerase II includes a function that is otherwise confined to remote activation domains of enhancer-bound transcription factors. We suggest that the CTD of RNA polymerase II contains a "portable" remote activation domain that may also facilitate chromatin opening within the transcription unit.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826625     DOI: 10.1002/mrd.1080390215

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  8 in total

1.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Developmental acquisition of enhancer function requires a unique coactivator activity.

Authors:  S Majumder; Z Zhao; K Kaneko; M L DePamphilis
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

4.  The Drosophila TATA binding protein contains a strong but masked activation domain.

Authors:  M Um; J L Manley
Journal:  Gene Expr       Date:  2000

5.  Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.

Authors:  Kristina Becanovic; Mahmoud A Pouladi; Raymond S Lim; Alexandre Kuhn; Paul Pavlidis; Ruth Luthi-Carter; Michael R Hayden; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

6.  Nucleosome structure of the yeast CHA1 promoter: analysis of activation-dependent chromatin remodeling of an RNA-polymerase-II-transcribed gene in TBP and RNA pol II mutants defective in vivo in response to acidic activators.

Authors:  J M Moreira; S Holmberg
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

7.  A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb.

Authors:  Fan Zhang; Matjaz Barboric; T Keith Blackwell; B Matija Peterlin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

8.  MIR sequences recruit zinc finger protein ZNF768 to expressed genes.

Authors:  Michaela Rohrmoser; Michael Kluge; Yousra Yahia; Anita Gruber-Eber; Muhammad Ahmad Maqbool; Ignasi Forné; Stefan Krebs; Helmut Blum; Ann Katrin Greifenberg; Matthias Geyer; Nicolas Descostes; Axel Imhof; Jean-Christophe Andrau; Caroline C Friedel; Dirk Eick
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.